Phase 1 Study of Ulixertinib (BVD 523) in Patients with Advanced Solid Malignancies
Ontology highlight
ABSTRACT: Phase 1 Study of Ulixertinib (BVD 523) in Patients with Advanced Solid Malignancies
PROVIDER: PRJNA882457 | ENA |
REPOSITORIES: ENA
ACCESS DATA